Pursuant to the relevant provisions of SESI (Listing Obligations and Disclosure Requirements), Regulations 2015, SMS Pharmaceuticals has informed that the officials of the Company will be meeting Investors/Analysts (Participants) on 20th August 2021. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 (6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. The changes may happen due to exigencies on the part of Host / Company.
The above information is a part of company’s filings submitted to BSE.
